Unknown

Dataset Information

0

Polycomb-Mediated Disruption of an Androgen Receptor Feedback Loop Drives Castration-Resistant Prostate Cancer.


ABSTRACT: The lethal phenotype of castration-resistant prostate cancer (CRPC) is generally caused by augmented signaling from the androgen receptor (AR). Here, we report that the AR-repressed gene CCN3/NOV inhibits AR signaling and acts in a negative feedback loop to block AR function. Mechanistically, a cytoplasmic form of CCN3 interacted with the AR N-terminal domain to sequester AR in the cytoplasm of prostate cancer cells, thereby reducing AR transcriptional activity and inhibiting cell growth. However, constitutive repression of CCN3 by the Polycomb group protein EZH2 disrupted this negative feedback loop in both CRPC and enzalutamide-resistant prostate cancer cells. Notably, restoring CCN3 was sufficient to effectively reduce CPRC cell proliferation in vitro and to abolish xenograft tumor growth in vivo Taken together, our findings establish CCN3 as a pivotal regulator of AR signaling and prostate cancer progression and suggest a functional intersection between Polycomb and AR signaling in CRPC. Cancer Res; 77(2); 412-22. ©2016 AACR.

SUBMITTER: Fong KW 

PROVIDER: S-EPMC5243151 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Polycomb-Mediated Disruption of an Androgen Receptor Feedback Loop Drives Castration-Resistant Prostate Cancer.

Fong Ka-Wing KW   Zhao Jonathan C JC   Kim Jung J   Li Shangze S   Yang Yeqing A YA   Song Bing B   Rittie Laure L   Hu Ming M   Yang Ximing X   Perbal Bernard B   Yu Jindan J  

Cancer research 20161104 2


The lethal phenotype of castration-resistant prostate cancer (CRPC) is generally caused by augmented signaling from the androgen receptor (AR). Here, we report that the AR-repressed gene CCN3/NOV inhibits AR signaling and acts in a negative feedback loop to block AR function. Mechanistically, a cytoplasmic form of CCN3 interacted with the AR N-terminal domain to sequester AR in the cytoplasm of prostate cancer cells, thereby reducing AR transcriptional activity and inhibiting cell growth. Howeve  ...[more]

Similar Datasets

2017-02-19 | GSE79358 | GEO
2017-02-19 | GSE79357 | GEO
2017-02-19 | GSE79356 | GEO
| S-EPMC4757469 | biostudies-literature
| PRJNA315571 | ENA
| S-EPMC3510497 | biostudies-literature
| S-EPMC3283034 | biostudies-literature
| S-EPMC10193960 | biostudies-literature
| S-EPMC5805650 | biostudies-literature
| S-EPMC5397168 | biostudies-literature